
ALPHA TEKNOVA INC
TKNONASDAQTrading Snapshot
- Day Range
- $7.45 β $7.56
- 52-Week Range
- $1.91 β $7.75
- Volume
- $5.12B
- Avg Volume
- $3.63B
- Shares Outstanding
- 53.6M
- Next Earnings
- Sep 27, 2026
Fundamentals Snapshot
- Annual Revenue
- $41M
- Last Q Revenue
- $12M
- P/E Ratio
- -23.9
- P/S Ratio
- 9.2x
- EPS (TTM)
- $-0.31
- Dividend Yield
- 0.00%
Why Investors Own TKNO
- βHigh-growth profile β revenue up +3.6% YoY with expanding US Equity exposure.
- βHealthy economics β 68% gross margin and 14% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ALPHA TEKNOVA INC
Alpha Teknova, Inc. supplies vital scientific reagents to the life sciences sector across both the United States and international markets. These crucial materials play a key role in facilitating the exploration, evolution, and ultimate production of biopharmaceutical goods, such as advanced drug treatments, new vaccines, and molecular diagnostic solutions. The company's product offerings encompass pre-filled media plates designed for cell growth and replication; liquid cell culture media and complementary supplements that promote cellular proliferation; and various molecular biology reagents used for the handling, rehydration, and purification of samples. Teknova caters to a diverse clientele within the life sciences arena, including pharmaceutical companies, biotechnology firms, contract development and manufacturing organizations (CDMOs), in vitro diagnostic businesses, and academic and governmental research facilities. Founded in 1996, Alpha Teknova's main office is situated in Hollister, California.
Otter Score Breakdown
βAnalyst Ratings
βLatest News & Updates

This Best Buy Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday
Top Wall Street analysts upgraded various stocks, including BBY, BCE. See what other analysts think.
BTIG Upgrades Alpha Teknova to Buy, Announces $8 Price Target
BTIG analyst Mark Massaro upgrades Alpha Teknova (NASDAQ:TKNO) from Neutral to Buy and announces $8 price target.

Alpha Teknova, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-09. The following slide deck was published by Alpha Teknova, Inc.

Alpha Teknova Q2 Earnings Call Highlights
Alpha Teknova (NASDAQ:TKNO) reported second-quarter revenue growth of 18% from a year earlier, surpassing $12 million for its highest quarterly revenue in the companyβs 30-year history. The company raised its full-year revenue outlook, citing first-half performance and confidence in the second half

Alpha Teknova Inc (TKNO) (Q2 2026) Earnings Call Highlights: Record Revenue and Raised Guidance ...
Alpha Teknova Inc (TKNO) posts highest quarterly revenue in company history, up 18% year-over-year, and lifts full-year 2026 outlook to $45-$47 million.
Alpha Teknova (NASDAQ:TKNO) Beats Q2 Estimates and Raises Full-Year Guidance
Alpha Teknova beats Q2 expectations with 18% revenue growth, raises FY2026 guidance, and improves cash flow, boosting stock 7%.